How tampon nanoplastic particles affect gynecological health
The influence of tampon nanoplastic particles on gynecological mucosal barriers
['FUNDING_R21'] · OREGON STATE UNIVERSITY · NIH-11013326
This study is looking at how tiny plastic particles from tampons might affect the vaginal and cervical tissues, helping us understand if they could cause problems like inflammation or hormonal changes, which could lead to serious health issues.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON STATE UNIVERSITY (nih funded) |
| Locations | 1 site (CORVALLIS, UNITED STATES) |
| Trial ID | NIH-11013326 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of nanoplastic particles released from tampons on the mucosal barriers of the vagina and cervix. It aims to identify the chemical characteristics of these particles and their physiological effects when they come into contact with gynecological tissues. The study will explore how these particles may penetrate protective barriers, potentially leading to inflammation, hormonal disruptions, and increased risks of conditions such as cervical cancer and endometriosis. By understanding these interactions, the research seeks to provide insights into the safety of menstrual hygiene products.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who menstruate and use tampons as their primary menstrual hygiene product.
Not a fit: Patients who do not use tampons or those who have undergone surgical procedures affecting their gynecological health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved safety standards for menstrual hygiene products and better health outcomes for individuals who menstruate.
How similar studies have performed: While the specific focus on tampon nanoplastics is novel, there is growing evidence that similar studies on nanoplastics in other contexts have shown significant health implications.
Where this research is happening
CORVALLIS, UNITED STATES
- OREGON STATE UNIVERSITY — CORVALLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOGG, KAITLIN C — OREGON STATE UNIVERSITY
- Study coordinator: FOGG, KAITLIN C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.